Uncategorized
FDA approves Lucentis prefilled syringe
Genentech’s pre-filled Lucentis (ranibizumab injection) syringe has been approved by the FDA, the company announced.The 0.5 mg prefilled syringe was approved to treat patients with wet age-related macular degeneration and macular edema after retinal vein occlusion and is the first pre-filled anti-VEGF medication to be approved by the FDA, the announcement said.